| Literature DB >> 32723701 |
K C Bergmann1, M Maurer1, M K Church1, T Zuberbier1.
Abstract
Entities:
Keywords: Anaphylaxis; Asthma; Mepolizumab; Omalizumab
Mesh:
Substances:
Year: 2020 PMID: 32723701 DOI: 10.18176/jiaci.0492
Source DB: PubMed Journal: J Investig Allergol Clin Immunol ISSN: 1018-9068 Impact factor: 4.333